Rarity PBC is a Public Benefit Corporation advancing and commercializing life-saving genetic therapies for rare diseases. Guided by a mission to enable responsible development and broad patient reach, Rarity integrates scientific rigor with sustainable, mission-driven operations to deliver therapies beyond development and into the hands of patients worldwide.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/29/25 | $4,600,000 | Seed |
Nemean Asset Management | undisclosed |
